DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 77 filers reported holding DYNE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,156 | +15.8% | 25,129 | +45.4% | 0.00% | – |
| Q2 2023 | $194,411 | -36.4% | 17,281 | -34.8% | 0.00% | – |
| Q1 2023 | $305,510 | +105.6% | 26,520 | +106.9% | 0.00% | – |
| Q4 2022 | $148,584 | -12.5% | 12,820 | -4.2% | 0.00% | – |
| Q3 2022 | $169,888 | +73.1% | 13,377 | -6.4% | 0.00% | – |
| Q2 2022 | $98,145 | -24.2% | 14,286 | +6.4% | 0.00% | – |
| Q1 2022 | $129,436 | -36.6% | 13,427 | -21.7% | 0.00% | – |
| Q4 2021 | $204,000 | -22.4% | 17,148 | +6.0% | 0.00% | – |
| Q3 2021 | $263,000 | -26.5% | 16,170 | -4.9% | 0.00% | – |
| Q2 2021 | $358,000 | – | 17,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |